Clopidogrel
Product Images NDC 67296-1840

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 14 technical images submitted to the FDA as part of the official labeling for Clopidogrel (NDC 67296-1840). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

505 (Clopidogrel 30s)

505 (Clopidogrel 30s)
Clopidogrel is a medication available in tablet form. Each tablet contains 97.875 mg of clopidogrel bisulfate which is equivalent to 75 mg of clopidogrel base. The usual dosage is mentioned on the package insert. The medication should be stored at 20° to 25°C (68° to 77°F) with excursions permitted to 15° to 30°C (59° to 86°F). A Medication Guide is available for patients and it can be accessed at www.macleodspharma.com/usa. The tablets are manufactured by Macleods Pharmaceuticals Ltd, Baddi, Himachal Pradesh, INDIA and distributed by Macleods Pharma USA, Inc. The NDC number for this medication is 33342-060-07.*
FDA Label Image

505 (Clopidogrel 500s)

505 (Clopidogrel 500s)
Each tablet contains 97.875 mg of clopidogrel bisufate, USP equivalent to 75 mg of clopidogrel base. Clopidogrel usual dosage is BEPARER. The tablets are 45x28 mm and should be stored between 20°C to 25°C (68° to 77°F), with excursions permitted to 15°C to 30°C (50 to 86° F) [see USP Reau s © | Controlled Room Temperature]. The package insert should be consulted for further details. This product is sold by Pharmascs and the website is wokmadeodsphama.comiusa. The place of origin is Naciecas ShamaUSA, Magaoss Prarmacescsi. The product name is not available due to incomplete text.*
FDA Label Image

505 (Clopidogrel 90s)

505 (Clopidogrel 90s)
This text is a description of a medication called clopidogrel, which comes in tablet form. Each tablet contains 97.875 mg of clopidogrel bisulfate, USP. This is equivalent to 75 mg of clopidogrel base. The usual dosage is specified in the package insert. The tablets should be stored between 20° to 25°C (68° to 77°F), with excursions permitted. The pharmacist is instructed to give each patient an enclosed Medication Guide. The medication is manufactured by Macleods Pharma USA, Inc. The code number is HP/152/07. There are 90 tablets available.*
FDA Label Image

505 (Clopidogrel Carton 100s)

505 (Clopidogrel Carton 100s)
This is a description of a medication called Clopidogrel Tablets, USP 75 mg manufactured by Macleods Pharma USA. The medication guide is available on their website. Each bottle contains 100 tablets with a batch number of 12|9. The tablets should be stored at room temperature with excursions permitted. It is recommended to see the package insert for dosage instructions.*
FDA Label Image

189 (Clopidogrel Fig 3)

FDA Label Image

Figure-1 (Clopidogrel Figure 01)

FDA Label Image

Figure-2 (Clopidogrel Figure 02)

Figure-2 (Clopidogrel Figure 02)
The text provides a comparison between two medications, PLACEBO (+ aspirin)® and CLOPIDOGREL (+ aspirin), over a follow-up period of 12 months. A result of 0.00009 is shown in the comparison. Other standard therapies were also used during the study.*
FDA Label Image

Figure-4 (Clopidogrel Figure 04)

Figure-4 (Clopidogrel Figure 04)
This is a clinical trial report that compares the effect of clopidogrel against placebo on the survival rate of patients. Both groups of participants received aspirin. The study found that the group treated with clopidogrel had a 7% proportional risk reduction of death compared to the placebo group. The report includes a graph showing the mortality rate over time for the two groups.*
FDA Label Image

146 (Clopidogrel Figure 05)

FDA Label Image

Fig-7 (Clopidogrel Figure 07)

Fig-7 (Clopidogrel Figure 07)
This is a medical report providing the names of two medications, Aspirin and Clopidogrel. Additionally, there is a statistical value of P=0.045, and mention of months of follow-up. No further information is available for a complete description of the medical study or report.*
FDA Label Image

Figure-3 (Clopidogrel Figure 3)

Figure-3 (Clopidogrel Figure 3)
This text seems to be a mix of random numbers and letters without proper context. It is not-available for creating a useful description.*
FDA Label Image

Figure-6 (Clopidogrel Figure 6)

FDA Label Image

Figure-8 (Clopidogrel Figure 8)

FDA Label Image

Structure (Clopidogrel Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.